 Download
the PDF version
of the projects' catalogue [19.2 Mb] |
| ADVAC-EC |
Advanced Vaccinology Training for Scientists from ACC and Developing Countries: From Genomics to Vaccination Strategies for Communicable Diseases Linked to Poverty |
| AIDS-CoVAC |
Generation of a Coronavirus-Based Multigene AIDS Vaccine and Evaluation in a Preclinical SIV model |
| Allomicrovac |
A combined microbicidal-immunizing strategy against SIV and HIV infection |
| AntiMal |
Development of New Drugs for the Treatment of Malaria |
| Auto/AlloCell-HIV |
Development of a Novel Therapeutic HIV-1 Vaccine: Horizontal Gene Transfer by Using Apoptotic HIV-1 DNA Containing Activated T-cells |
| AVIP |
Aids Vaccine Integrated Project |
| BioMalPar |
Biology and Pathology of the Malaria Parasite |
| CASCADE |
Concerted Action on SeroConversion to AIDS and Death in Europe |
| CILMALVAC |
The Tetrahymena system as an innovative approach to malaria antigene expression |
| CPN-YAS-PRD |
Contact Point Network to Attract Young African Scientists to Participate in EU-Funded PRD Research Projects |
| DEC-VAC |
Development of a Dendritic Cell-targeted Vaccine against AIDS |
| DETECTHIV |
Sensitive Nanoparticle Assay For the Detection of HIV |
| EAGLES |
European Action in Global Life Sciences - Health Programme |
| EMPRO |
European Microbicides project |
| EMVDA |
The European Malaria Vaccine Development Association |
| EPIVAC |
Development of a multi-step Improved Epidermis Specific Vaccine Candidate against HIV/AIDS |
| EPI-VAC |
Identification of Novel Epitopes as HIV-1 Vaccine Candidates |
| EURHAVAC |
European Network for Harmonisation of MalariaVaccine Development |
| EuropeHIVResistance |
European Cohort Coordinating Network on HIV Drug Resistance |
| EUROPRISE |
European Vaccines and Microbicides Enterprise |
| EuroSIDA 2005-2009 |
The EuroSIDA Network 2005-2009 – Clinical and Virological Outcome of Patients with HIV under Care in Europe |
| ExCellENT-HIT |
Exploiting Cellular Transport of Nuclear Transcripts as HIV Innovative Therapy |
| FASTEST-TB |
Development and Clinical Evaluation of Fast Tests for Tuberculosis Diagnosis |
| GISHEAL |
Genetic and Immunological Studies of European and African HIV-1+ Long Term Non-Progressors |
| HIDDEN HIV CHALLENGE |
Challenging the Hidden HIV: Understanding the Block on Transcriptional Reactivation to Eradicate Infection |
| HIV PI resistance |
HIV protease inhibitor resistance by enzyme- substrate coevolution |
| HIV VIROSOMES |
Development of a New Vaccine Against HIV: Virosomes Incorporating HIV proteins |
| HIVResInh |
Preparation and Identification of New HIV Reverse Transcriptase
Inhibitors Targeted Against HIV Strains Resistant to anti-HIV/AIDS
drugs |
| HIVAB |
Generation of Broadly Cross Neutralising Antibodies for Innovative Active-passive HIV Vaccination Strategies Based on Modified Ig-gene Transgenic Mice |
| HIVSTOP |
Development of an Effective RNA Interference-Based Anti-HIV-1 Therapy Using an SV40-Derived Vector |
| HUMALMAB |
Human monoclonal antibodies as tools for malaria research and therapy |
| Immuno VacTB |
A new approach for developing a less Immunosuppressive Vaccine for Tuberculosis |
| INNOVAC |
Highly Innovative Strategies for Vaccination to Poverty Related Diseases |
| Malaria Age Exposure |
Age of Exposure and Immunity to Malaria in Infants |
| MalariaPorin |
Validation of the Plasmodium Aquaglyceroporin as a Drug Target |
| MALINV |
Differential Expression of Malaria Invasion-Associated Proteins in the porozoite: Novel Vaccination Strategy |
| MILD-TB |
Immunogenicity of Mycobacterium Tuberculosis lipids in the Non Replicating Status of latency |
| MM-TB |
Molecular Markers of M. tuberculosis Early Interactions with Host Phagocytes |
| MPCM |
Pathogenic Role of MicroParticles in Cerebral Malaria |
| MUNANO VAC |
Mucosal Nano Vaccine Candidate for HIV |
| MUVAPRED |
Mucosal Vaccines for Poverty Related Diseases |
| MVACTOR |
Host Immune Activation Optimised Vaccinia Virus Vectors for Vaccine Development |
| MYCOMANCY |
Transcriptional Regulation And Cellular Localisation Of Mycobacterial Cell Cycle Proteins During Dormancy |
| NEAT |
The European AIDS Treatment Network |
| Neotim |
Innate and adaptive immunity in clinical and experimental mycobacterial infection in neonates and infants |
| NeutNet |
Standardisation of HIV Neutralisation Assays to be Used in Vaccine Research and Clinical Trials |
| NEWHIVTARGETS |
Identifying novel classes of HIV inhibitors |
| NEWTBDRUGS |
New Drugs for Persistent Tuberculosis: Exploitation of 3-D Structure of Novel Targets, Lead Optimisation and Functional In-Vivo Evaluation |
| NM4TB |
New Medicines for Tuberculosis |
| PENTA/ECS |
Paediatric European Network for Treatment of AIDS and European Collaborative Study on HIV-infected pregnant women and their children |
| PHARMA-PLANTA |
Recombinant Pharmaceuticals from Plants for Human Health |
| Pox-gene |
A Combined Pox-virus/Lentiviral Vector System to Treat HIV Infection; Immunisation and Direct In Vivo Gene Transfer in T-Lymphocytes |
| PRIBOMAL |
Preclinical Studies towards an Affordable, Safe and Efficacious Two-Component Paediatric Malaria Vaccine |
| Plasmodium dUTPase |
Deoxyuridine Triphosphate Nucleotidohydrolase as a Drug Target against Malaria |
| READ-UP |
Redox Antimalarial Drug discovery |
| RMVHIV |
Recombinant Measles Virus as a Vector for HIV Vaccines |
| scrIN-SILICO |
Finding Promising Drug Candidates Against Tuberculosis with
Multidisciplinary Protocol Based Non-Conventional Search |
| SENSITIVE TARGETS |
Oxygen-Sensitive Enzymes of the Mevalonate-Independent Isoprenoid Biosynthesis Pathway as Targets for New Antimalarial and Anti-TB Drugs |
| SERO-TB |
Development of a Specific Serological Kit for the Diagnosis of TB |
| SHIVA |
Selection and Development of Microbicides for Mucosal Use to Prevent Sexual HIV Transmission/Acquisition |
| SIGMAL |
Targeting Malaria Transmission Through Interference with Signalling in Plasmodium falciparum Gametocytogenesis |
| SME Malaria |
SME Led Malaria Vaccine Initiative |
| TB Treatment Marker |
Establishing a TB Treatment Efficacy Marker |
| TBMACS |
Identification and characterisation of Mycobacterium tuberculosis virulence genes involved in macrophage parasitism |
| TBADAPT |
Effect of Genetic Variation in Mycobacterium Tuberculosis on Vaccine Escape and the Acquisition of Drug Resistance |
| TB-DRUG OLIGOCOLOR |
Development of a Molecular Platform for the Simultaneous Detection of Mycobacterium tuberculosis Resistance to Rifampicin and Fluoroquinolones |
| TBIRIS |
Pathogenesis and identification of predictive factors of TB-IRIS in HIV patients under HAART |
| TB-trDNA |
Evaluation of Transrenal-DNA Detection to Diagnose Tuberculosis |
| TB-VAC |
TB-VAC: An Integrated Project for New Vaccines against Tuberculosis |
| Teach CD4 |
International CD4 T-Lymphocyte Training Programme for the Support of HIV Clinical Trials Networks |
| TIP-VAC |
Explaining and Improving Efficacy of Targeted Immunodeficiency Virus-like Particle Vaccines against AIDS |
| TRIoH |
Targeting Replication and Integration of HIV |
| Tuberculosis China |
The Diversity of Mycobacterium Tuberculosis Strains in China: Tracing the Origins of the Worldwide Dispersion of the Multidrug-Resistant Beijing Genotype |
| UNITE-MORE |
Uniformity in Testing and Monitoring HIV Resistance |
| Vaccines4TB |
Genome- and HLA- Wide Scanning and Validation of Cytotoxic CD8 T Cell Responses against Mycobacterium Tuberculosis |
| VaccTIP |
Vaccine Strategies for Combined Targeting of Innate and Adaptive Immune Pathways |
| VIAV |
Very Innovative AIDS Vaccine |
| VirApt |
Antiviral Aptamers for Treatment of HIV-1 Infection |
| VITBIOMAL |
Vitamin Biosynthesis as a Target for Antimalarial Therapy |